Related Experiment Video
Updated: Feb 15, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes
Julie A Lovshin1,2, Geneviève Boulet3, Yuliya Lytvyn2
1Division of Endocrinology and Metabolism and.
Background:
In type 1 diabetes (T1D), adjuvant treatment with inhibitors of the renin-angiotensin-aldosterone system (RAAS), which dilate the efferent arteriole, is associated with prevention of progressive albuminuria and renal dysfunction. Uncertainty still exists as to why some individuals with long-standing T1D develop diabetic kidney disease (DKD) while others do not (DKD resistors). We hypothesized that those with DKD would be distinguished from DKD resistors by the presence of RAAS activation.
Methods:
Renal and systemic hemodynamic function was measured before and after exogenous RAAS stimulation by intravenous infusion of angiotensin II (ANGII) in 75 patients with prolonged T1D durations and in equal numbers of nondiabetic controls. The primary outcome was change in renal vascular resistance (RVR) in response to RAAS stimulation, a measure of endogenous RAAS activation.
Results:
Those with DKD had less change in RVR following exogenous RAAS stimulation compared with DKD resistors or controls (19%, 29%, 31%, P = 0.008, DKD vs. DKD resistors), reflecting exaggerated endogenous renal RAAS activation. All T1D participants had similar changes in renal efferent arteroilar resistance (9% vs. 13%, P = 0.37) irrespective of DKD status, which reflected less change versus controls (20%, P = 0.03). In contrast, those with DKD exhibited comparatively less change in afferent arteriolar vascular resistance compared with DKD resistors or controls (33%, 48%, 48%, P = 0.031, DKD vs. DKD resistors), indicating higher endogenous RAAS activity.
Conclusion:
In long-standing T1D, the intrarenal RAAS is exaggerated in DKD, which unexpectedly predominates at the afferent rather than the efferent arteriole, stimulating vasoconstriction.
Funding:
JDRF operating grant 17-2013-312.
Insights
In type 1 diabetes, exaggerated renin-angiotensin-aldosterone system (RAAS) activity, particularly in the afferent arteriole, distinguishes those who develop diabetic kidney disease from those who resist it.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Research
Background:
- Type 1 diabetes (T1D) management often includes RAAS inhibitors to prevent kidney disease.
- However, the reasons some T1D patients develop diabetic kidney disease (DKD) while others do not (DKD resistors) remain unclear.
- This study investigates the role of RAAS activation in DKD development in T1D.
Purpose of the Study:
- To determine if individuals with diabetic kidney disease (DKD) exhibit distinct patterns of renin-angiotensin-aldosterone system (RAAS) activation compared to DKD resistors in long-standing type 1 diabetes (T1D).
- To assess endogenous RAAS activation by measuring changes in renal vascular resistance (RVR) following exogenous RAAS stimulation.
Main Methods:
- Compared hemodynamic function in 75 T1D patients and controls before and after angiotensin II infusion.
- Measured changes in renal vascular resistance (RVR) as a primary outcome to assess endogenous RAAS activation.
- Differentiated between DKD, DKD resistors, and controls.
Main Results:
- Individuals with DKD showed less change in RVR after RAAS stimulation, indicating heightened endogenous RAAS activation compared to DKD resistors and controls.
- While efferent arteriolar resistance changes were similar in all T1D groups, DKD patients exhibited reduced afferent arteriolar vascular resistance changes, suggesting increased RAAS activity.
- These findings point to an exaggerated intrarenal RAAS in DKD, predominantly affecting the afferent arteriole.
Conclusions:
- In long-standing T1D, diabetic kidney disease is associated with an exaggerated intrarenal renin-angiotensin-aldosterone system (RAAS).
- This heightened RAAS activity unexpectedly occurs at the afferent arteriole, leading to vasoconstriction.
- Understanding this mechanism may offer new therapeutic targets for preventing DKD in T1D.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hormonal Regulation
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Standing Waves
Modes of Standing Waves - I

